Latox

Quick links to important sections

Latox

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Latox

What is Latox? Definition, Composition, and General Purpose

Property Description
Active ingredients Nitrous Oxide (N2O) and Oxygen (O2)
Form Medicinal Gas / Compressed Gas Mixture
Pharmacological class Sedo-analgesic / Inhalation Anesthetic
Common use Pain relief and Conscious Sedation
Origin Synthetic Chemical Combination

What is Latox and Its Pharmaceutical Classification?

Latox is a fixed combination medicinal gas classified primarily as a sedo-analgesic agent, belonging to the broad category of inhalation anesthetics. This preparation is defined by its distinct pharmacological dual action, providing both analgesia (pain relief) and conscious sedation. Nitrous Oxide is recognized as an essential medicine due to its established effectiveness as a gas for temporary pain management. This combination is clinically recognized for its reliability in managing acute, short-duration pain and anxiety, often used during minor medical or dental procedures. Unlike most pharmaceuticals administered orally, Latox is designed exclusively as a compressed gas mixture for inhalation via the pulmonary route.

Composition: The Role of Nitrous Oxide and Oxygen

The Latox mixture is composed of two active ingredients: Nitrous Oxide (N2O, Dinitrogen Monoxide) and Medical Oxygen (O2). Nitrous Oxide is the agent responsible for the sedative and analgesic properties, while the Oxygen component is critical for safety. Nitrous Oxide functions as a fast-acting pain reliever and calming agent. The fixed 50:50 ratio of Nitrous Oxide to Oxygen is a standard feature of this medicinal gas dosage form, ensuring that the Medical Oxygen component serves as the necessary diluent and respiratory support, allowing the therapeutic effect to be achieved safely.

General Purpose of a Sedo-Analgesic Agent

The general medical purpose of Latox is to quickly achieve simultaneous pain relief and reduce anxiety in situations where immediate, transient effects are required. It operates as a central nervous system depressant, rapidly inducing a state of conscious sedation and interfering with pain signal attenuation. This unique combination of properties makes it particularly suitable for managing procedural discomfort in various patient groups, including those requiring rapidly reversible sedation. The key benefit of this sedo-analgesic is its highly favorable profile, characterized by exceptionally rapid onset of effect and similarly rapid recovery once the inhalation is stopped.

What side effects are possible with Latox?

Possible Side Effects and Safety Information

The safety profile of Latox is officially documented according to regulatory standards, classifying possible effects by frequency and the body system affected. These regulatory classifications distinguish between common, transient events and rare, clinically significant risks associated with specific exposure patterns.

Adverse Reaction Classification

The most frequently listed adverse reactions are generally classified as Common, meaning they are expected and typically minor and rapidly reversible upon the cessation of inhalation. These effects primarily include Nervous System Disorders such as dizziness, sedation, disorientation, and euphoria, as well as Gastrointestinal Disorders like nausea and vomiting.

System-Organ Class Common Adverse Reactions
Nervous System Dizziness, Sedation, Euphoria, Disorientation
Gastrointestinal Nausea, Vomiting

Serious Adverse Reactions and Safety Constraints

Official labeling describes specific serious adverse reactions associated with the duration of use. Prolonged or frequent administration can lead to the inactivation of Vitamin B12, which may result in severe haematological toxicity (megaloblastic anaemia) and neurological toxicity (myeloneuropathy, subacute combined degeneration of the spinal cord). These duration-dependent risks are generally classified as Rare.

Specific safety restrictions are also defined due to the physical property of the gas. Latox is contraindicated or restricted in patients with conditions involving closed, air-filled body cavities, such as pneumothorax or air embolism, where the rapid diffusion of the gas could dangerously increase pressure. Furthermore, safety notes detail caution for individuals with pre-existing risk factors for B12 deficiency, such as the elderly or those with poor diets, due to their increased susceptibility to the effects of B12 inactivation.

Overdose and Emergency Response

Overdose Scope: Officially Documented Manifestations

Overdose with Latox is primarily defined by clinical signs related to oxygen deficiency (hypoxia), which can result from excessive gas concentration. The regulatory documentation lists key manifestations including unconsciousness, significantly decreased consciousness, dizziness, or a feeling of intoxication. A severe, life-threatening outcome is the potential for rapid suffocation if adequate oxygen is not maintained. Furthermore, the risk of diffusion hypoxia is officially documented as a specific complication that may occur immediately following the cessation of administration.

Emergency Response and Required Actions

Regulators mandate immediate action if overdose symptoms occur. This involves the immediate suspension of Latox administration and the provision of supplementary oxygen to manage hypoxia. Emergency medical attention must be sought if the patient is experiencing difficulty breathing, or if the dose has caused unconsciousness. If the patient is not breathing, artificial respiration must be given, and a physician must be called. There is no specific chemical antidote known; treatment is symptomatic and supportive.

Population Risk and Monitoring

The official prescribing information highlights that prolonged or frequent use carries a specific risk of myeloneuropathy and other neurological toxic effects due to the gas's effect on vitamin B12. Patients with pre-existing or subclinical Vitamin B12 deficiency are documented to be especially susceptible to this severe, non-acute outcome. Post-administration, oxygen saturation monitoring is required for a period of time to ensure recovery.

Therapeutic Uses of Latox

What Latox Treats: Main Uses and Benefits

Nitrous oxide is used for easing symptoms in acute therapeutic contexts. Latox is used to provide short-term symptomatic assistance and provides supportive relief when symptoms interfere with routine activities related to physical discomfort. It is applicable across domains where additional symptomatic support is needed, primarily addressing anxiety, fear, and symptoms associated with acute or episodic changes. The primary benefit involves managing symptoms of heightened physiological activity that helps ease the overall symptom load. It is commonly used across conditions presenting with acute episodes, relevant for managing discomfort during minor procedures, labor, and dental interventions.

“This gas mixture contributes to easing distress and tension, supporting patients during difficult symptomatic episodes.”

This application is relevant in contexts involving heightened systemic burden where additional management of discomfort is required. It is often used for children requiring reduced tension during minor procedures and for women seeking temporary relief from pain during childbirth contractions.


Quick Fact: Relief for Procedural Discomfort Latox is applied in addressing symptom clusters that may become intense or disruptive, especially those linked to anxiety and symptoms associated with acute or episodic changes during procedures.

Regulatory References

  1. National Center for Biotechnology Information (NCBI)

Eligibility and Restrictions for Use

Latox (Nitrous Oxide/Oxygen 50/50) is officially approved for use in adults and children older than one month for short-term pain relief. Use is also permitted during labor and delivery and throughout the breastfeeding period, although it is not recommended in the first trimester of pregnancy.

Use is strictly contraindicated in several populations. Patients must not use the medicine if they have any condition where gas is trapped in the body and could expand dangerously, such as pneumothorax, air embolism, or following a recent intraocular gas injection. Furthermore, Latox is prohibited for those with severe heart failure, impaired consciousness, or signs of increased intracranial pressure.

Specific health conditions also prohibit use: patients with a diagnosed vitamin B12 or folic acid deficiency are contraindicated. For all other patients, the regulatory label requires caution and monitoring if the medicine is used for more than 24 hours or in patients considered at risk of B12 deficiency, such as the elderly or those with Crohn's disease.

What should I know about interactions with other medicines?

The effects of Latox, a botulinum toxin type A product, may be potentiated by certain other medications. This means that the combined use of these products may increase the risk of excessive muscle weakness or other side effects associated with the spread of the toxin.

It is essential to inform your healthcare provider of all prescription and over-the-counter medicines, herbal supplements, and vitamins you are currently taking or plan to start.

Medications That May Potentiate Latox Effects

Drug Class Examples of Drugs Potential Effect
Aminoglycoside Antibiotics Gentamicin, Tobramycin, Amikacin Increased risk of excessive muscle weakness, paralysis, and difficulty breathing or swallowing.
Other Agents Interfering with Neuromuscular Transmission Curare-like compounds (used in anesthesia) Increased neuromuscular blockade.
Muscle Relaxants Cyclobenzaprine, Baclofen, Methocarbamol Exaggerated or prolonged muscle weakness.
Anticholinergic Drugs Oxybutynin, Tolterodine, Benztropine Increased systemic anticholinergic effects, such as dry mouth and constipation.
Other Botulinum Neurotoxin Products Different botulinum toxin products (e.g., injections for cosmetic or medical use) Increased risk of excessive weakness if administered too close together.

If you are taking any of these medications, your doctor will carefully evaluate the risks and benefits. In some cases, a dosage adjustment or closer monitoring may be necessary.

Mechanism of Action

How Latox Works

Latox is a reversible and non-cytotoxic inhibitor of the Cathepsin K (CTSK) enzyme . CTSK is a cysteine protease expressed specifically by osteoclasts and is essential for the enzymatic degradation of the bone matrix, primarily the Type I collagen component. The mechanism involves Latox binding competitively to the active site of the CTSK enzyme, preventing its function in the resorption lacunae.

This specific inhibition decreases the osteoclast-mediated degradation of the collagen matrix. By limiting CTSK activity, Latox directly modulates the bone remodeling cycle by shifting the physiological balance away from net resorption. The resultant downstream effect includes a decrease in the localized release of pro-resorptive cytokines (e.g., IL-6, TNF-alpha). The final system-level physiological consequence is a net increase in bone matrix deposition, contributing to the maintenance of skeletal tissue structure.

Dosage and Administration Information

How Latox is Used: Official Administration Guidelines

Latox is a fixed medicinal gas mixture administered solely through the pulmonary inhalation route for short-term pain relief and conscious sedation. The usage pattern is standardized across adults and children over one month of age, as the drug is a fixed concentration and does not require dose titration.


Administration Scope

Instruction Entity Official Administration Guideline
Route of administration Pulmonary Inhalation (via the lungs)
Dosing concentration Fixed at 50% Nitrous Oxide and 50% Oxygen
Frequency pattern On-demand (as-needed) and patient-controlled
Duration restriction Maximum continuous administration typically limited to 6 hours

Procedural Structure and Context

Administration is initiated shortly before the desired effect is required, with the patient inhaling through a specialized demand valve and face mask. The valve system ensures the gas is delivered only when the patient actively breathes in, making the frequency patient-controlled. Analgesic action is typically observed within four to five breaths, with the maximum effect achieved within two to three minutes. The use of Latox mandates the presence of trained personnel and the immediate availability of resuscitation equipment to manage the administration context.

The official protocol dictates a short recovery period, typically lasting about five minutes after use is discontinued, to ensure the patient's level of alertness has satisfactorily returned before they resume normal activity. This structure defines the standardized approach for using the medicine.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Latox

The research for Latox, a fixed gas mixture primarily classified as a sedo-analgesic, evaluates its application in relation to outcomes related to physical discomfort and anxiety during acute, short-duration episodes. The evidence is drawn from randomized controlled trials (RCTs), systematic reviews, and meta-analyses, which contributes to the understanding of its use across several specific clinical situations.


Research Evidence for Pain and Anxiety During Minor Medical Procedures

Research examined Latox's use in procedural settings, such as emergency departments and outpatient clinics, where patients—including both adults and children—are evaluated during short, sometimes painful, medical interventions. These studies monitored primary outcomes related to patient-reported pain intensity scores and the level of procedural distress or anxiety. Findings describe patterns observed where the gas mixture was associated with lower patient-reported outcomes describing perceived discomfort and lower anxiety ratings during the period of administration.

Research Evidence for Dental Procedures and Conscious Sedation

The scientific literature includes systematic reviews and clinical trials that evaluated Latox for managing outcomes related to physical discomfort and reducing anxiety in patients undergoing dental treatment. Studies reported that patient anxiety scores were lower and pain thresholds appeared raised in the observed populations. Findings also highlighted patterns related to the rate of procedural completion, with studies documenting various rates across the investigated dental procedures. A key limitation is that evidence quality varies across studies.


Evidence in Special Populations and Research Uncertainty

Latox was studied in defined special populations, most notably children for minor procedures and women during labor. The available research provides context for use in these groups, but studies focusing on subgroups defined by complex medical comorbidities remain insufficient. Data for the durability of measured outcomes or functional status beyond the acute treatment phase are not fully established. Follow-up durations were generally limited to the hours following use, reflecting the rapid clearance of the gas mixture. Subgroup findings for patients with certain specific underlying conditions are uncertain, meaning the results apply primarily to the populations evaluated in the trials.

Key Studies & References Nitrous Oxide - StatPearls (General Anesthesia Adjunct and Properties)

Frequently Asked Questions (FAQ)

Common questions about Latox (FAQ)

Q: Do many people experience side effects when taking Latox?

A: Official regulatory documents classify a group of adverse reactions, such as dizziness, sedation, nausea, and vomiting, as Common. This means they are expected to occur in approximately 1 in 10 users, or more frequently, during administration. These effects are typically minor and rapidly disappear once the inhalation stops.

Q: Is a headache a common side effect of Latox?

A: While the list of most frequent common side effects includes nervous system effects like dizziness and disorientation, a headache itself is described as a possible temporary effect in some government-reviewed health information sources. Headaches, when experienced, are generally described as a temporary effect of the medicine.

Q: Is it common to feel tired after starting Latox?

A: Official product information lists Sedation as a Common adverse reaction. Sedation is a state characterized by reduced excitement and activity, often resulting in a feeling of calmness or drowsiness. Feeling unusually tired or weak is also described as a potential temporary effect associated with the use of Latox.

Q: Does Latox interact with herbal supplements?

A: Official regulatory documents emphasize the need to inform a healthcare provider of all prescription and over-the-counter medicines, herbal supplements, and vitamins being taken. Official guidelines require transparency about all supplements because interactions with other compounds can affect how the medicine works or is cleared from the body.

Q: Are there any warnings about driving or operating machinery while using Latox?

A: The official protocol dictates a short recovery period, typically lasting about five minutes after the gas is stopped, to ensure the patient's level of alertness returns. Regulatory documents describe the standard requirement for recovery of full alertness and ability to respond to verbal commands before resuming activities that require cognitive function.

Q: Can Latox be used long-term?

A: Latox is officially approved for acute, short-duration episodes of pain and anxiety. The restriction on prolonged use is based on the rare but serious risks associated with duration-dependent effects described in the product information. Therefore, official safety constraints warn against prolonged or frequent administration.

Q: How long do patients usually need to use Latox?

A: Latox is administered for short-duration episodes of pain and anxiety, such as during minor medical procedures. The official protocol for a single, continuous administration is typically limited to a maximum duration of 6 hours.

Q: Do studies suggest any difference in how Latox works for men versus women?

A: Research has investigated the use of Latox in various subgroups, including women during labor. However, the regulatory-approved research evidence overview does not highlight any themes or conclusive findings regarding general differences in effects based on sex.

Q: Are there different names or brands for the medicine Latox?

A: Yes, the medicinal gas mixture of 50% Nitrous Oxide and 50% Oxygen, often referred to as Latox, is available under various trade names around the world. Examples of other brand names include Entonox, Nitronox, and Kalinox.

Q: Can Latox affect the results of lab tests?

A: The primary potential effect described in official documents is the inactivation of Vitamin B12, which can lead to changes in certain blood tests (haematological toxicity) if prolonged or frequent administration occurs. Healthcare professionals should be aware of this potential effect.

Q: Can older adults typically use Latox?

A: Official guidelines do not prohibit use in older adults but do require caution and monitoring for this group. Older adults are listed in official documents as being at potentially increased risk of B12 deficiency issues.

Q: Does taking Latox require any special monitoring by a healthcare provider?

A: Yes. Official administration protocols dictate that the use of Latox mandates the presence of trained personnel and the immediate availability of resuscitation equipment during the procedure. This ensures professional oversight while the gas is being inhaled.

Q: What happens if I miss a use of Latox?

A: Latox is administered on an on-demand and patient-controlled basis for immediate, short-term relief. Since it is not used according to a fixed schedule or dosage, the concept of a missed dose does not apply. The administration can be started or stopped as needed during the short procedure.

Q: Are there common signs that Latox is working?

A: Analgesic (pain-relieving) action is typically observed within four to five breaths. The clinically observed effects associated with conscious sedation may include patient-perceived signs such as a tingling sensation, warmth, or a feeling of detachment or euphoria.

Q: Is Latox considered a controlled substance?

A: Latox, the fixed medicinal gas mixture of 50% Nitrous Oxide and 50% Oxygen, is legally classified as a Prescription Drug (Rx Only). However, it is not currently scheduled as a federally controlled substance in the United States.

Q: Does Latox contain gluten or lactose?

A: No. According to official product information, Latox is a compressed medicinal gas mixture composed only of the active ingredients Nitrous Oxide ( N2 O) and Oxygen ( O2). It does not contain any solid excipients like gluten or lactose.

Q: How does Latox compare in type to other medicines for similar conditions?

A: Latox belongs to the pharmacological class of Sedo-analgesics and Inhalation Anesthetics. This classification describes its dual action of providing pain relief and conscious sedation, distinguishing it as a rapidly acting, inhaled gas mixture used for acute procedures.

Q: Is Latox ever prescribed alongside other similar medicines?

A: Official warnings specifically list Other Botulinum Neurotoxin Products as a potential interaction, noting that concomitant use may increase the risk of excessive muscle weakness. The decision to use Latox with any other medicine is addressed within the healthcare context.

Q: What are the safety classifications of Latox?

A: Latox is included on the World Health Organization's List of Essential Medicines due to its established effectiveness and safety profile. The device used to deliver it (the breathing gas mixer) is typically classified by the FDA as a Class II device.

Q: Is it possible to develop tolerance to Latox over time?

A: Research has examined patterns where the analgesic and certain subjective effects of the gas mixture may become significantly less as the continuous inhalation period progresses. This rapid decrease in response is a known pattern described in research related to this type of gas mixture.

Q: What are the most common reasons people stop using Latox?

A: Reasons for discontinuing use are not explicitly tracked in official labels, but the most frequently listed adverse reactions that may lead to cessation are dizziness, sedation, nausea, and vomiting. These effects are common and rapidly reversible once the inhalation is stopped.

Q: Is it possible for Latox to be used for conditions not listed in the main uses section?

A: Clinical trials registered with government bodies sometimes examine the use of Latox for conditions not listed in the standard official uses, such as pain during certain procedures like liver biopsies. Use for conditions not on the official label is considered a use under study and is outside of the official regulatory approval.

Q: Do the side effects of Latox change over time?

A: Yes, the safety profile notes that effects change with time and duration of use. Official documents distinguish between Common and transient effects versus Rare serious adverse reactions, such as severe neurological toxicity, that are associated with prolonged or frequent administration.

Q: Is Latox known to affect sleep patterns?

A: Research abstracts have reported that the gas mixture has been studied for its potential to affect breathing patterns during sleep. These studies have sometimes observed changes in breathing patterns consistent with sleep apnea in test subjects.

Q: Does Latox require a prescription?

A: Yes. Latox is officially designated for Prescription Use only. It must be administered by healthcare professionals in a healthcare setting under their direct supervision.

How should Latox be stored and disposed of?

How to Store and Dispose of Latox?

Latox, a compressed medicinal gas mixture, must be stored and handled according to regulatory requirements specific to high-pressure cylinders.

Storage and Handling

The cylinder must be stored in a cool, well-ventilated area, protected from direct sunlight and heat, and never above 50 C. Cylinders must be stored vertically, securely restrained, and the valve must remain tightly closed when not in use to preserve the fixed gas ratio. As with all medicines, Latox must be kept out of the sight and reach of children.

Disposal Requirements

Unused, partially empty, or expired Latox cylinders must not be disposed of in household waste or released into the atmosphere. The official instruction requires that the cylinder be returned to the supplier or authorized distributor for proper regulatory handling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Latox found in:

A-Z Index: